Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 2/2018

01-02-2018 | Original Contributions

Laparoscopic Sleeve Gastrectomy for Morbid Obesity in Patients After Orthotopic Liver Transplant: a Matched Case-Control Study

Authors: Levan Tsamalaidze, John A. Stauffer, Lisa C. Arasi, Diego E. Villacreses, Jose Salvador Serrano Franco, Steven Bowers, Enrique F. Elli

Published in: Obesity Surgery | Issue 2/2018

Login to get access

Abstract

Introduction

Obesity is frequently encountered in patients with orthotopic liver transplant (OLT). The role of bariatric surgery is still unclear for this specific population. The aim of this study was to review our experience with laparoscopic sleeve gastrectomy (LSG) after OLT.

Material and Methods

We performed a retrospective case-control study of patients undergoing LSG after OLT from 2010 to 2016. OLT-LSG patients were matched by age, sex, body mass index (BMI), and year to non-OLT patients undergoing LSG. Demographics, operative variables, postoperative events, and long-term weight loss with comorbidity resolution were collected and compared between cases and controls.

Results

Of 303 patients undergoing LSG, 12 (4%) had previous OLT. They were matched to 36 non-OLT patients. No difference was found between groups in the American Society of Anesthesiologists class, mean operative time, or postoperative morbidity. The non-OLT group, however, had a significantly shorter mean hospital stay than the OLT group (1.7 vs 3.1 days; P < .001). There were no conversions to open procedures. For patients with long-term follow-up, change in BMI after LSG was similar between the groups, but the non-OLT patients had significantly more excess body weight loss at 2 years (53.7 vs 45.2%; P < .001). Similar resolution of comorbid conditions was noted in both groups. LSG caused no changes in dosage of immunosuppressive medications, and no liver complications occurred.

Conclusion

LSG after OLT in appropriately selected patients appears to have similar outcomes to LSG in non-OLT patients.
Literature
1.
Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25(1):134–42.CrossRefPubMed
2.
Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28.CrossRefPubMed
3.
Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring, Md). 2008;16(10):2323–30.CrossRef
4.
Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20(6):859–63.CrossRefPubMed
5.
Singh S, Watt KD. Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. Mayo Clin Proc. 2012;87(8):779–90.CrossRefPubMedPubMedCentral
6.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed
7.
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant: Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(2):363–8.CrossRef
8.
Bhati C, Idowu MO, Sanyal AJ, et al. Long term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis related cirrhosis. Transplantation. 2017.
9.
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249–53.CrossRefPubMed
10.
Richards J, Gunson B, Johnson J, et al. Weight gain and obesity after liver transplantation. Transplant Int: Off J Eur Soc Organ Transplant. 2005;18(4):461–6.CrossRef
11.
Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2011;17(1):15–22.CrossRef
12.
El Atrache MM, Abouljoud MS, Divine G, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transpl. 2012;26(5):E505–12.CrossRef
13.
14.
Office of the Surgeon G, Office of Disease P, Health P, Centers for Disease C, Prevention, National Institutes of H. Publications and Reports of the Surgeon General. The Surgeon General’s Call To Action To Prevent and Decrease Overweight and Obesity. Rockville (MD): Office of the Surgeon General (US); 2001.
15.
Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation. Obes Surg. 2007;17(11):1517–9.CrossRefPubMed
16.
Elli EF, Masrur MA, Giulianotti PC. Robotic sleeve gastrectomy after liver transplantation. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2013;9(1):e20–2.CrossRef
17.
Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.CrossRefPubMed
18.
Khoraki J, Katz MG, Funk LM, et al. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2016;12(1):75–83.CrossRef
19.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
20.
Sarela AI, Dexter SP, O'Kane M, et al. Long-term follow-up after laparoscopic sleeve gastrectomy: 8–9-year results. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(6):679–84.CrossRef
21.
Weiss H, Nehoda H, Labeck B, et al. Organ transplantation and obesity: evaluation, risks and benefits of therapeutic strategies. Obes Surg. 2000;10(5):465–9.CrossRefPubMed
22.
Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis: Off J Natl Kidney Found. 1999;34(1):1–13.CrossRef
23.
Gentileschi P, Venza M, Benavoli D, et al. Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. Obes Surg. 2009;19(10):1460–3.CrossRefPubMed
24.
25.
Kumar N, Bazerbachi F, Rustagi T, et al. The influence of the Orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg. 2017;
26.
Tichansky DS, Madan AK. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg. 2005;15(10):1481–6.CrossRefPubMed
Metadata
Title
Laparoscopic Sleeve Gastrectomy for Morbid Obesity in Patients After Orthotopic Liver Transplant: a Matched Case-Control Study
Authors
Levan Tsamalaidze
John A. Stauffer
Lisa C. Arasi
Diego E. Villacreses
Jose Salvador Serrano Franco
Steven Bowers
Enrique F. Elli
Publication date
01-02-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 2/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2847-7

Other articles of this Issue 2/2018

Obesity Surgery 2/2018 Go to the issue

Letter to the Editor

Liver Dysfunction with Both Roux-en-Y and One-Anastomosis Gastric Bypass Is Almost Exclusively Seen with Longer Than Standard Limb Lengths

Review Article

The Effect of Helicobacter pylori on Postoperative Outcomes in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis

Original Contributions

Perceived Social Support for Exercise and Weight Loss in Adolescents Undergoing Sleeve Gastrectomy

Original Contributions

Efficacy of Goal-Directed Fluid Therapy via Pleth Variability Index During Laparoscopic Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients

Original Contributions

The Long-Term Effects of the Adjustable Gastric Band on Esophageal Motility in Patients Who Present for Band Removal

Letter to the Editor

Remission of Sjogren’s Syndrome after Roux-en-Y Gastric Bypass for Morbid Obesity